Stay updated with the latest in Intellectual Property (IP) news through our blog! We provide periodic updates on newly filed Inter Partes Reviews (IPRs), as well as patent-related news and updates from various Technological Fields. Get the latest scoop on Patent news from tech Giants like Apple, Tesla, and more, along with updates from the Pharmaceutical Industry. Stay informed and ahead of the game with our comprehensive blog on IP news and updates !

Cup of Curiosi Tea

  

Canadian Certificates of Supplementary Protection (CSP)

Eligibility Criteria (Regulatory): 
  • The regulatory approval for the drug must be the first for that particular drug as the statute authorizing the CSP specifically excludes minor variations of pharmaceuticals that have previously been granted marketing approval.
  • Application for marketing approval in Canada must have been made within one year of a first international submission for regulatory approval of the drug in the EU (or any member country of the EU), the United State, Australia, Switzerland, or Japan.
Eligibility Criteria (Patent):

  • Must be in force.
  • Contain at least one claim covering the approved product, its use, or a method of producing the product. 
Time Period of Application:
  • Either within 120 days following the issuance of regulatory approval in Canada or within 120 days of the patent’s grant date, whichever occurs later.
Maximum Period of Protection:
  • 24 Months
Source: http://www.hc-sc.gc.ca/dhp-mps/prodpharma/applic-demande/guide-ld/csp/csp-guide-cps-ld-eng.php

Fact File: Canada is the last country in G7 countries (Canada, France, Germany, Italy, Japan, United kingdom and the USAto provide additional benefits!

Post Comment

No comments

Securing Your Name as a Trademark: A Strategic Move for public figures

In today's competitive landscape, it's becoming increasingly common to hear news about public figures whether they are celebrities, ...